BeyondSpring Inc. Operating Lease, Weighted Average Discount Rate, Percent
BeyondSpring Inc. (BYSI) had Operating Lease, Weighted Average Discount Rate, Percent of 5.00% as of 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-03-25
- 2025-12-31: Operating Lease, Weighted Average Discount Rate, Percent 5.00%.
- 2024-12-31: Operating Lease, Weighted Average Discount Rate, Percent 5.10%.
- 2023-12-31: Operating Lease, Weighted Average Discount Rate, Percent 5.10%.
- 2022-12-31: Operating Lease, Weighted Average Discount Rate, Percent 3.60%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2025-12-31 | 5.00% 10-K · filed 2026-03-25 |
| 2024-12-31 | 5.10% 10-K · filed 2026-03-25 |
| 2023-12-31 | 5.10% 10-K · filed 2025-03-27 |
| 2022-12-31 | 3.60% 20-F · filed 2023-04-18 |
| 2021-12-31 | 5.50% 20-F · filed 2023-04-18 |
| 2020-12-31 | 8.90% 20-F · filed 2022-04-14 |
| 2019-12-31 | 8.40% 20-F · filed 2021-04-30 |
| 2019-09-30 | 8.45% 6-K · filed 2019-12-18 |
| 2019-06-30 | 9.05% 6-K · filed 2019-09-18 |
| 2019-03-31 | 9.05% 6-K · filed 2019-07-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |